Madison, Wisconsin, November 30th, 2022 – Nimble Therapeutics, an industry-leading peptide therapeutics company, today announced the appointment of Pete Gough,

October 24, 2022 | For Immediate Release Former Healthcare Research Analyst and Investment Banker Expands Firm’s Operational Depth and Sector

San Francisco, June 30, 2022 – Telegraph Hill Partners (THP), a venture capital and growth equity firm dedicated to building

The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to

Boulder, CO: Mosaic Biosciences (“Mosaic” or “the Company”), a protein and antibody discovery company that helps its partners identify next-generation

MADISON, WI, USA, [05/17/2022] — Nimble Therapeutics Inc. today announced the company has achieved the first development milestone for each

Marcy l’Étoile, France, April 12th 2022 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that

The integration of TrakCel’s OCELLOS and Lash Group’s Fusion aims to improve speed-to-therapy by increasing connectivity between providers and hub

Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank  

MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and